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The  essential  oil  of  Chenopodium  ambrosioides  L.,  Amaranthaceae,  was  obtained  by  steam  distillation  in
a  Clevenger  apparatus  and  characterization  was  performed  using  chromatographic  and  spectroscopic
assays  (GC-FID,  GC/MS, 1H NMR).  Two  major  compounds  were  identiﬁed:  p-cymene  (42.32%) and  ascari-
dole (49.77%).  The  ethanolic  extract and  hydrolate  were  fractionated  by  liquid–liquid  partitioning  and  the
compounds  were  characterized  by GC/MS.  The essential  oil,  ethanol  extract  and  fractions  by  partitioning
with  dicloromethane,  ethyl  acetate  and  butanol  were  tested  in  tumor  cell  lines  (K562,  NALM6,  B15,  andhenopodium ambrosioides
scaridole
-Cymene
ssential oil
ytotoxic
as chromatographic
RAJI).  Signiﬁcant  cytotoxic  activity  was  found  for essential  oil (IC50 = 1.0  g/ml)  for RAJI  cells  and  fraction
dicloromethane  (IC50 =  34.0  g/ml)  and  ethanol  extract  (IC50 =  47.0  g/ml)  for  K562  cells.  The  activity  of
the  essential  oil  of  C.  ambrosioides  is  probably  related  to the  large  amount  of  ascaridol,  since  the  other
major  compound,  p-cymene,  is  recognized  as  a potent  anti-inﬂammatory  and  has  low  cytotoxic  activity.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Chenopodium ambrosioides L., Amaranthaceae, popularly known
s “erva-de-santa-maria” or “mastruc¸ o” (Kokanova-Nedialkova
t al., 2009), has been widely used in folk medicine in the midwest,
outh and southeast of Brazil and is found mainly in temperate
nd subtropical countries (Lorenzi and Matos, 2002). The leaves
re used as an anthelmintic and vermicide (Alitonou et al., 2012)
nd this species is also used in the treatment of gastrointesti-
al, respiratory, vascular, and nervous diseases and to combat
iabetes and hypercholesterolemia. Furthermore, it presents seda-
ive, antipyretic, and antirheumatic effects (De Feo and Senatore,
993). Due to these properties, in 2009, the Brazil’s Health Min-
stry selected the C. ambrosioides as one of the plants of interest to
he Helth Sistem (Renisus) that can be used as an herbal medicine.
The geographical area where C. ambrosioides is obtained, with
ariable humidity, temperature and general environmental condi-
ions and the degree of evolutionary and genetic variability (the
ossible existence of chemotypes within the species) are factors
hat directly inﬂuence the chemical composition of the essential
∗ Corresponding author.
E-mail: angela@univali.br (A. Malheiros).
http://dx.doi.org/10.1016/j.bjp.2015.08.012
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraoil obtained from this plant (Gobbo-Neto and Lopes, 2007; Chekem
et al., 2010). However, despite this variability, the essential oil con-
sists mainly of mono and sesquiterpenes (Kliks, 1985; Cruz et al.,
2007).
Various studies have been undertaken to characterize the
composition of the essential oil of C. ambrosioides by gas chro-
matography coupled to mass spectrometry (GC/MS). The main
compounds found are: (Z)-ascaridole, (E)-ascaridole, carvacrol, p-
cymene, ˛-terpinene and limonene (Cavalli et al., 2004; Jardim
et al., 2008; Chekem et al., 2010; Vieira et al., 2011). Studies
on the essential oil showed antifungal activity against Aspergillus
fumigatus, Aspergillus niger, Botryodiplodia theobromae, Fusarium
oxysporum, Sclerotium rolfsii, Macrophominapha seolina, Cladospo-
rium cladosporioides, Helminthosporim oryzae,  and Pythiumdeba
ryanum at a concentration of 100 g/ml (Matos, 2011). Monzonte
et al. (2007) noted that the essential oil of C. ambrosioides presents
in vitro activity against the protozoan Leishmania donovani, causing
irreversible inhibition of their growth.
Kinupp (2007) describes this species as also being rich in
ﬂavonoids and terpenoids and having very diverse pharmacologi-
cal activities, including antioxidant and chemopreventive effects
against cancer, as well as antimicrobial, anti-inﬂammatory, and
analgesic properties (Cruz et al., 2007; Dembitsky et al., 2008;
Grassi, 2011). According to Hmamouchi et al. (2000), the extract
 Ltda. All rights reserved.
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btained from this species presents potential molluscicidal activ-
ty against snails transmitting schistosomiasis, Bulinus truncatus
LC90 = 2.23 mg/l). Patrício et al. (2008), on the other hand, studied
he effect of the aqueous crude extract of the leaves of C. ambro-
ioides on skin ulcers induced by Leishmania amazoniensis in mice.
ntralesional treatment was able to inhibit the progression of the
lcer.
Some authors, cited by Matos (2011), reported that the anti-
nﬂammatory activity of Chenopodium is due mainly to ascaridole,
hich is one of the major components of the essential oil of this
lant. This same compound can also exhibit antipyretic effects and
as been indicated as being responsible for growth inhibition in
ifferent tumor cell lines. Its action is so signiﬁcant in vitro that is a
trong candidate for the treatment of cancer (Efferth et al., 2002).
Given the above, the objective of this study was to obtain
nd characterize the essential oil and fractions from the hydro-
ate and ethanol extract of leaves of C. ambrosioides through
hromatographic and spectrometric assays (GC-FID, GC/MS, 1H
MR) and evaluate its cytotoxicity in vitro by the MTT  method
3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in
ifferent tumor cell lines: myeloid leukemia (K562), acute B lym-
hoblastic leukemia (NALM6 and B15), and Burkitt’s lymphoma
RAJI), since cancer is a major public health problem worldwide
INCA, 2011).
aterials and methods
lant material
Chenopodium ambrosioides L., Amaranthaceae, was  obtained in
arch 2010 in Cáceres, a city in the state of Mato Grosso, Brazil. Tax-
nomic identiﬁcation of the collected material was done by botanist
.Sc. Oscar Benigno Iza by comparison with authentic samples. The
xsiccate was deposited in the Herbarium Barbosa Rodrigues (HBR),
tajaí, SC, with the registry number 52802.
xtraction of the essential oil
The essential oil of the leaves of C. ambrosioides, which had been
ried and weighed (148 g), was obtained by steam distillation in a
levenger apparatus. The leaves were extracted with 3 l of distilled
ater in the ﬂask, and the extraction was performed over a period
f 4 h. The oil was removed with a micropipette and, to prevent
xidation reactions due to the remaining water, anhydrous sodium
ulfate was added. The oil was stored frozen, protected from light.
ydrolate and ethanolic extract
After the extraction of the essential oil, the water was ﬁltered
o yield about 2.75 l of hydrolate. The leaves used for oil extrac-
ion (approximately 185 g) were subjected to maceration in ethanol
or 7 days. Approximately 1 l each of the hydrolate and ethanolic
xtract were subjected to liquid–liquid partitioning with immisci-
le solvents in increasing order of polarity (dichloromethane, ethyl
cetate and butanol). For each solvent, two extractions were per-
ormed using ﬁrst 400 ml  and then 200 ml  of the solvent. After the
eparation of the phases, anhydrous sodium sulfate was  added to
he organic phase to remove the remaining water. The obtained
ractions were ﬁltered and concentrated in a rotary evaporator at
 maximum temperature of 50 ◦C to obtain a dry residue. Aliquots
f these fractions were sent for analysis by GC/MS.nalysis by chromatographic and spectroscopic assays
The essential oil obtained from the dried leaves of C.
mbrosioides was analyzed by gas chromatography with ae Farmacognosia 26 (2016) 56–61 57
ﬂame ionization detector (GC-FID) and by gas chromatogra-
phy coupled to mass spectrometry (GC/MS Shimadzu QP2010
S). The analysis by GC-FID, with an Rtx-1 capillary column
(30 m × 0.25 mm × 0.10 m),  used helium as the carrier gas
(0.8 ml/min); the injector temperature was  180 ◦C and the detector
temperature was  250 ◦C, 1:50 split, using the following temper-
ature program: 80–200 ◦C at 20 ◦C/min, 200–300 ◦C at 15 ◦C/min;
300–310 ◦C at 12 ◦C/min; FID (310 ◦C); H2: 40 ml/min.
The fractions obtained from the hydrolate and ethanol extract
and the essential oil were analyzed by GC/MS with an injector
temperature of 250 ◦C; the temperature program was 80–200 ◦C
at 20 ◦C/min; 200–300 ◦C at 15 ◦C/min, with other conditions equal
to those of GC-FID. The identiﬁcation of the chemical composition
of the essential oil and fractions was  performed by comparing the
mass spectra obtained with the data available in the library (NIST
version 8.0).
The 1H NMR  spectra were obtained on a Bruker AC-300 MHz
300F. Spectra were obtained in deuterated chloroform (purity
99.8% + 0.05% TMS) obtained from Cambridge Isotope Laboratories
Inc., with tetramethylsilane as the internal reference (TMS). Chemi-
cal shifts were recorded in dimensionless values  (ppm) indicating
the sign as singlet (s), doublet (d), triplet (t), etc.
1H NMR  (CDCl3, 300 MHz) essential oil consisting mainly of
ascaridole and p-cymene. Ascaridole : 1.03 (d, J = 6.9, H9, H10),
1.39 (s, H7), 1.52 (d, J = 9.0, H5), 1.91 (sept, J = 6.9, H8), 2.07 (d, J = 9.0,
H6), 6.43 (d, J = 8.7, H3), 6.51 (d, J = 8.7, H2). p-Cymene : 1.26 (d,
J = 6.9, H9, H10), 2.34 (s, H7), 2.90 (n, J = 6.9, H8), 7.16 (s, H3, H4, H5,
H6).
The essential oil, ethanol extract and dichloromethane, ethyl
acetate and butanol fractions from the extract were evaluated for
cytotoxicity using K562 (myeloid leukemia), Nalm6 and B15 (acute
B lymphoblastic leukemia), and RAJI (Burkitt’s lymphoma) cells.
Cell viability was assessed by the MTT  (3 (4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay, which is based on a
method using a dye, i.e.  a tetrazolium salt soluble that is in water
which is converted to purple formazan after reduction by mito-
chondrial dehydrogenases in viable cells (Mosmann, 1983).
Cells were grown in appropriate plastic dishes with DMEM
(Dulbecco’s Modiﬁed Eagle’s Minimum Essential Medium), sup-
plemented with fetal calf serum (FBS) 10% inactivated for 1 h
at 56 ◦C, 10 mM of ethanesulfonic acid hydroxyethyl piperazine
(HEPES), 1.5 g/l of sodium bicarbonate, 1% of penicillin G (100 U/ml),
100 mg/ml  of streptomycin, 50 g/ml of amphotericin B in an
incubator humidiﬁed at 37 ◦C with 5% CO2 emissions. Before the
experiments, the number of viable cells was  determined by the try-
pan blue exclusion method, with counts performed in a Neubauer
chamber.
Cells were plated using epMotion® 5070 equipment (Eppendorf,
Vaudaux, Schonenbuch, Switzerland) which distributed 2 × 104
cells per well in 96-well plates, which were incubated with the
test substances at different concentrations (0.01, 0.1, 1, 10, 100 and
1000 mg/ml) for 48 h at 37 ◦C in 5% CO2. DMSO was  used for solubi-
lization of the test substances in a maximum concentration of 0.1%
well/treatment; this concentration is not cytotoxic to the cells. Dox-
orubicin at the same concentrations tested was  used as a positive
standard.
After the treatment period, the medium was  removed and
100 l of the MTT  solution was added at 0.5 mg/ml in the cul-
ture medium and incubated for 4 h. After that time, the medium
was removed and the formazan precipitate was dissolved in 100 l
DMSO/well and reading was performed on a microplate reader at
540 nm (Bio-Tek Power Wave XS). The optical density obtained
in the control group, i.e.  untreated cells (incubated with growth
medium only), was regarded as 100% viable cells in order to
establish concentration vs. response curves, and therefore the
IC50 (concentration inhibiting 50% growth of cell), according to
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he equation below. Each experiment was performed in tripli-
ate and repeated at least three times. Results are expressed as
ean ± standard deviation values. For IC50 calculation was  used
onlinear regression Prism 5.0 software for windows
elative viability = Teste sample absorbance
Control absorbance
×  100
esults and discussion
The process of extracting the essential oil from C. ambrosioides
as conducted by steam distillation with a Clevenger appara-
us. The essential oil obtained was called CAEO, with a yield
f 1.15%. After extraction, an aliquot of the oil was  analyzed
y GC-FID (Fig. 1), displaying two major peaks with retention
imes of 3.614 and 5.064 min, which were identiﬁed by com-
arison of the mass spectra in the standards of the NIST 8.0
ibrary as 1-isopropyl-4-methyl-benzene (p-cymene or p-cymol 1)
42.32%) and 1-isopropyl-4-methyl-2,3 dioxabicyclo [2.2.2] oct-5-
ne (ascaridole 2) (49.77%), respectively. These two monoterpenes
mounted to 92.09% of the essential oil. Of the remaining 7.91% of
he essential oil, only two  compounds showed percentages above
%, but these were not identiﬁed in NIST library version 8.0.
O
1 2
O
According to the literature, it is known that the chemical com-
osition of the oil varies greatly according to its region of origin
nd its method of extraction. As a result, variations in the percent-
ge of analyzed compounds can be observed. p-Cymene, shown to
ake up 42.32% of the essential oil, differed little from a study by
apondjou et al. (2002), who found that the oil contained 50% p-
ymene. Research by Jardim et al. (2008) on the essential oil of C.
mbrosioides obtained in Brazil, Cavalli et al. (2004) in Madagascar,
hekem et al. (2010) in Cameroon and Singh et al. (2008) in India,
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Fig. 1. Chromatogram obtained by GC-FID (180 ◦C) of thee Farmacognosia 26 (2016) 56–61
showed lower concentrations of p-cymene, with percentages of 2.0,
16.2, 23.4 and 25.77%, respectively.
Ascaridole appeared at a concentration of 49.77% in the oil. This
percentage was  close to that found in a study by Cavalli et al. (2004),
who found that the oil contained 55.3% ascaridole. This percentage
differed greatly compared to that found in a study by Vieira et al.
(2011), which found ascaridole as the major compound (87%). On
the other hand, Borges et al. (2012) found less ascaridole in the oil
obtained from the plant collected in northeastern Brazil (17.1%). In
a study on the essential oil from India, ascaridole was present as
only 7% of the oil composition (Gupta et al., 2002).
According to Johnson and Croteau (1984), ascaridole is a sensi-
tive heat component, which has a biosynthetic pathway related to
the formation of ˛-terpinene. Ascaridole may  undergo changes in
its conformation and become isoascaridole. Johnson and Croteau
(1984) assessed the thermal isomerization in ascaridole to isoas-
caridole by GC analysis of leaves and fruits of C. ambrosioides when
the injector temperature was above 200 ◦C. The thermal structural
rearrangement of ascaridole is known, but there have been few
studies on this reaction (Boche and Runquist, 1968). Cavalli et al.
(2004) reported that during the characterization of the essential
oil of C. ambrosioides from Madagascar, using GC-FID and GC/MS
assays, the partial isomerization of ascaridole into isoascaridole
occurred.
In the present study, when the oil was  analyzed by GC/MS with
an injection temperature of 250 ◦C it was observed that ascari-
dole (retention time of 5.550 min) was converted into its isomer,
isoascaridole (retention time of 6.001 min). So, the oil was also
evaluated by nuclear magnetic resonance of hydrogen (1H NMR)
(Fig. 2). The spectrum was obtained at room temperature and no
sign was detected that could be attributed to isoascaridole. This
technique has become an excellent tool for the analysis of essen-
tial oils because it allows for evaluating all hydrogens present in
a matrix, which can be complex. All signals observed in the 1H
NMR  spectrum were assigned to the hydrogens of the two  major
compounds. The signals relative to the other hydrogens of the com-
pounds were observed as noise in the baseline. From the analysis
of the integral of the signals, the ratio between p-cymene and
ascaridole could be established, which was 1:1.2. These data are
consistent with the information obtained by GC-FID.
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bFig. 2. 1H NMR  spectrum (300 MHz) of t
After extraction of the essential oil, the hydrolate was submitted
o partitioning with solvents of increasing polarity. These frac-
ions were called: partition hydrolate dichloromethane (PHDCM),
artition hydrolate ethyl acetate (PHEA), and partition hydrolate
utanol (PHB). The ﬁrst two were subjected to analysis by GC/MS
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e CAEO
Fig. 3. Gas chromatogram obtained by GC/MS (250 ◦C) of sampential oil of Chenopodium Ambrosioides.
for characterization, while the latter, due to its high polarity, was
not analyzed by this technique.
The leaves used for extraction of the oil, in turn, were further
subjected to extraction by maceration with ethanol. The extract was
also subjected to the liquid–liquid partition process. The fractions
6.0 6.5 7.0 7.5 8.0 8.5
5
6
10
7 8 9
les (a) PHDCM, (b) PHEA, (c) PEDCM, (d) PEEA, (e) CAEO.
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Table 1
Comparison of percentage of the compounds analyzed by GC/MS in the dichloromethane (PHDCM) and ethyl acetate (PHEA) hydrolate fractions and in the fraction of
dichloromethane of ethanol extract (PEDCM).
Peaks Fraction
PHDCM PHEA PEDCM
RT Area % RT Area % RT Area %
1 4.458 13.36 4.461 19.64 4.454 18.11
2  – – 5.642 1.26 – –
3  5.738 3.43 5.739 7.22 5.735 2.78
4  5.792 1.06 – – – –
5  5.847 3.46 5.848 6.65 5.842 3.24
6  5.986 41.84 5.982 17.65 5.976 23.60
7  6.090 11.11 6.090 11.21 6.084 8.51
8  6.249 3.66 6.249 1.37 6.250 1.33
9 6.333 1.58 – – – –
10  6.467 0.80 6.478 1.94 – –
11  6.569 19.68 6.573 31.27 6.560 17.93
12  – – 6.920 1.79 – –
Table 2
Cytotoxic effect (IC50 g/ml) of essential oil and fractions of the extract of Chenopodium ambrosioides and positive control (doxorubicin) against K562, NALM6, B15, and RAJI
cells.
Sample IC50 (g/ml)
K562 NALM6 B15 RAJI
Essential oil (CAEO) 86.1 ± 10.6 25.3 ± 3.6 >100 1.0 ± 0.2
Ethanolic extract of the leaves (CAEE) 47.0 ± 6.1 61.9 ± 6.4 >100 29.6 ± 6.9
Dichloromethane fraction (PEDCM) 34.0 ± 2.7 45.9 ± 5.6 >100 40.9 ± 6.5
Ethyl  acetate fraction (PEEA) >100 >100 >100 >100
Butanol fraction (PEB) >100 >100 >100 >100
Doxorrubicin 62.5 ± 18.1 5.8 ± 1.8 >100 13.2 ± 0.5
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3ata expressed as mean ± standard deviation values.
ere called: partition extract dichloromethane (PEDCM); partition
xtract ethyl acetate (PEEA); partition extract butanol (PEB). These
ractions, except for PEB, were subsequently analyzed by GC/MS.
he chromatograms obtained from fractions of the DCM and AE
ydrolates and the ethanol extract of C. ambrosioides were com-
ared and are shown in Fig. 3.
The chromatograms of the fractions PHDCM, PHEA, and PEDCM
ad peaks with similar retention times, indicating a similar chem-
cal composition, differing only in their concentrations (Table 1).
ydrolate partitioning was not efﬁcient because the same com-
ounds were detected in different fractions.
The mass spectra obtained from the hydrolate fraction DCM was
ompared with the mass spectra in NIST library version 8.0, but no
ompound was identiﬁed. It is suggested that many of these com-
ounds are derived from the degradation of the main compounds in
he essential oil due to heating during extraction. Peaks 5, 6, and 7,
ith retention times of 5.99, 6.09, and 6.25 min, respectively, corre-
pond to isomers of each other, since they have the same molecular
eight (170), one of which is possibly dihydroascaridol, and oth-
rs its isomers. Compound 10, corresponding to a retention time
f 6.57 min, is an isomer of ascaridol, with an identical molecular
ass (168).
After the characterization of essential oil and fractions obtained
rom the ethanol extract and hydrolate, samples CAEO, CAEE,
EDCM, PEEA and PEB were tested on different tumor cell lines:
yeloid leukemia (K562), acute B lymphocytic leukemia (NALM6
nd B15), and Burkitt’s lymphoma (RAJI). The results (Table 2) show
he potential cytotoxicity of the tested samples, especially CAEO,
hich showed an extremely low IC50 of 1 mg/ml  on RAJI cells, com-
ared to the IC50 of 13.2 mg/ml  of doxorubicin (positive control).
he fractions PEDCM and CAEE also showed lower IC50 values in
562 cells compared to doxorubicin (62.5 mg/ml), with values of
4 and 47 mg/ml, respectively.Efferth et al. (2002) isolated ascaridole from a commercial
preparation of the essential oil of C. ambrosioides and analyzed in
it using different strains of tumor cells in vitro (CCRF-CEM–human
lymphoblastic leukemia T cells, HL60 – promyelocytic leukemia,
and MDA  MB-231 – breast cancer). According to their results, it
was concluded that ascaridole showed cytotoxicity in the analyzed
cells. This study was the ﬁrst to demonstrate the importance of
ascaridole as a possible candidate for the treatment of cancer, and
reveals the need for further study of its cytotoxic action. Thus, it
can be suggested that the antitumor effect of the essential oil in
Burkitt’s lymphoma cells (RAJI) in the present study may  be related
to the high concentration of ascaridole.
Nascimento et al. (2006), on the other hand, investigated the
treatment effect of a hydroalcoholic extract of C. ambrosioides in
Ehrlich ascites tumor cells and observed that this species was able
to inhibit tumor growth when administered prior to tumor implan-
tation, i.e. two days after implantation. The authors also suggested
that this effect may  be related to the antioxidant properties of C.
ambrosioides.
The activity of the essential oil of C. ambrosioides is probably
related to the large amount of ascaridol, since the other major
compound, p-cymene, is recognized as a potent anti-inﬂammatory
(Chen et al., 2013) and has low cytotoxic activity (Koba et al., 2009).
Through the analysis of the essential oil of C. ambrosioides by
GC/MS and 1H NMR, it was possible to identify two major com-
pounds, i.e.  ascaridole and p-cymene, which were identiﬁed in
previous research and have been found in different concentrations.
This indicates the dependence of the region of collection and extrac-
tion conditions on the isolation of these compounds.The essential oil of C. ambrosioides and its fractions showed
cytotoxic potential. However, there are still few studies investi-
gating antitumor potential of C. ambrosioides. Studies further to
the present study toward identifying the mechanisms involved
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n inhibiting the proliferation of K562 and Raji tumor cells are
equired.
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